期刊文献+

Sirt1和P55PIK在胃癌中的表达及临床意义 被引量:2

Expression of Sirt1 and P55PIK in Gastric Cancer and Clinical Significance
下载PDF
导出
摘要 目的研究Sirt1和P55PIK在胃癌组织中的表达水平及其与临床病理参数的关系,并初步探讨Sirt1和P55PIK在胃癌组织中表达相关性。方法采用免疫组织化学方法检测45例胃癌组织及癌旁正常组织中Sirt1和P55PIK表达水平,同时提取15例胃癌及癌旁正常组织蛋白行Western blot检测Sirt1和P55PIK表达水平。结果 Sirt1和P55PIK在胃癌组织中的表达阳性率分别为55.56%和64.44%,明显高于癌旁组织中的24.44%和35.56%(P<0.05)。Sirt1和P55PIK表达与患者性别、年龄、肿瘤直径及浸润深度无明显相关性,但与胃癌TNM分期和淋巴结转移有关(P<0.05)。Western blot检测显示15例患者Sirt1和P55PIK在胃癌组织中表达水平明显高于癌旁正常组织。Spearman相关性分析显示,Sirt1与P55PIK在胃癌组织中表达呈正相关(r=0.363,P=0.015)。结论 Sirt1和P55PIK表达与胃癌淋巴结转移和肿瘤分期密切相关,表明在胃癌的发病过程中可能有Sirt1和P55PIK的参与,联合检测可作为判断胃癌预后和筛选高危转移患者的指标,并可作为有效的治疗靶点。 Objective To investigate the expression level of Sirt1 and P55PIK in the gastric cancer,and the correction between them.Methods Immunohistochemistry was used to detect the expression of Sirt1 and P55PIK mRNA and protein in 45 cases of gastric carcinoma and adjacent tissues.Western blot was used to detect the protein expression of Sirt1 and P55PIK in 15 cases of gastric carcinama and adiacent tissues.Results Positive rate of Sirt1 and P55PIK in gastric cancer was 55.56% and 64.44%,which was significantly higher than in the adjacent tissues(24.44% and 35.56%)(P0.05).The expression of Sirt1 and P55PIK in gastric cancer was not correlated with gender,age,tumor diameter and depth of invasion,but with TNM staging and lymph node metastasis(P0.05).Western blot revealed that the expression of Sirt1 and P55PIK in gastric carcinoma was higher than in the adjacent tissue.Spearman correlation analysis showed that Sirt1 and P55PIK in gastric cancer were positively correlated.Conclusion The expression of Sirt1 and P55PIK in gastric cancer is correlated with lymph node metastasis and tumor stage,suggesting their roles in the pathogenesis of gastric cancer.Combined detection of Sirt1 and P55PIK can be used to judge the prognosis of gastric cancer and screen the high risk of metastasis,and Sirt1 and P55PIK can serve as an effective therapeutic target.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2012年第6期735-739,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 SIRT1 P55PIK 胃癌 Sirt1 P55PIK gastric cancer
  • 相关文献

参考文献14

  • 1Firestein R, Blander G, Michan S, et al. The SIRT1 deacety- lase suppresses intestinal tumorigenesis and colon cancer growth[J]. PLoS One, 2008,3 (4) : e2020. 被引量:1
  • 2Ford J,Jiang M, Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival[J]. Cancer Res, 2005,65 (22) : 10457-10463. 被引量:1
  • 3Cheng H L, Mostoslavsky R,Saito S. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice[J]. Proc Natl Acad Sci U S A,200a, 100(19): 10794- 10799. 被引量:1
  • 4Yeung E,Hoberg J E,Ramsey C S, et al. Modulation of NF- kappaB-dependent transcription and cell survival by the SIRT1 deacetylase[J]. EMBO J, 2004,23 (12) : 2369-2380. 被引量:1
  • 5Hu J,Xia X,Cheng A, et al. A peptide inhibitor derived from P55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy[J]. Mol Cancer Ther, 2008,7(12) : 3719- 3728. 被引量:1
  • 6Vaziri H, Dessain S K, Ng E E, et al. hSIR2 (SIRTI) functions as an NAD-dependent p5a deacetylase[J]. Cell, 2001,107(2) : 149-159. 被引量:1
  • 7Smith J. Human Sir2 and the 'silencing' of p53 activity[J]. Trends Cell Biol,2002,12(9):404 406. 被引量:1
  • 8Wood J G, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans[J]. Nature, 2004,430 (7000) : 686-689. 被引量:1
  • 9Vanhaesebroeck B,Waterfield M D. Signaling by distinct clas- ses of phosphoinositide 3-kinases[J]. Exp Cell Res, 1999,253 (1) :239-254. 被引量:1
  • 10Wymann M P, Marone R. Phosphoinositide 3-kinase in dis- ease: timing, location, and scaffolding[J]. Curt Opin Cell Biol, 2005,17(2) : 141-149. 被引量:1

二级参考文献42

共引文献9

同被引文献43

  • 1冯安宁,樊祥山,黄勤,章宜芬,叶庆,吴鸿雁,杨军,张丽华.沉默信息调节因子2相关酶1在贲门癌中表达的意义及相互关系[J].医学研究生学报,2011,24(8):825-830. 被引量:2
  • 2Ma J, Sawai H, Ochi N, et al. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancre- atic cancer cells [J] . Mol Cell Biochem, 2009, 331 (1 - 2) : 161 - 171. 被引量:1
  • 3Tanic N, Milovanovic Z, Tanic N, et al. The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients [ J ] . Cancer Biol Ther, 2012, 13 (12) : 1165 -1174. 被引量:1
  • 4Tarnawski AS, Pai R, Tanigawa T, et al. PTEN silencing reverses aging - related impairment of angiogenesis in micro- vascular endothelial cells [ J ] . Biochem Biophys Res Com- mun, 2010, 394 (2): 291-296. 被引量:1
  • 5Guarente L, Franklin H. Epstein Lecture:Sirtuins, aging, and medicine[J]. N Engl J Med, 2011,364 (23):2235-2344. 被引量:1
  • 6Houtkooper RH, Pirinen E,Auwerx J. Sirtuins as regulators of metabolism and healthspan[J]. Nat Rev Mol Cell Biol, 2012,13 (4):225-238. 被引量:1
  • 7Yang H, Lee SM, Gao B,et al. Historic deaeetylase sirtuin l deacetylates IRF1 protein and programs dendritic cells to control Thl7 protein differ-entiation during autoimmune inflammation[J]. J Biol Chem,2013,288 (52):37256-37266. 被引量:1
  • 8Lin L, Zheng X, Qiu C, et al. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis[J]. Oncol Rep, 2014,32 (6):2831-2835. 被引量:1
  • 9Davenport AM, Huber FM, Hoelz A. Structural and functional analysis of human SIRT1 [J]. J Mol Biol, 2014,426 (3):526-541. 被引量:1
  • 10Yang H, Lee SM, Gao B, et al. Histone deaeetylase sirtuin 1 deaeetylates IRF1 protein and programs dendritic cells to control Thl7 protein differ-entiation during autoimmune inflammation[J]. Biol Chem, 2013,288 (52):37256-37266. 被引量:1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部